MaxInsight has received FDA 510(k) approval, August 6, 2007.

Clinical MEG analysis based on:

• Innovative software technology
• Easy operation
• Workflow concept
• Automated reporting
• Integration of all steps required in analysis routine

MaxInsight in a nutshell:

• MEG/EEG data import, DICOM import
• Spike detection in selected modalities
• Reconstruction of dipole clusters
• Averaging of different spike groups
• DICOM export of dipole locations
• Automated reporting

MaxInsight uses an unique workflow concept which allows the user to perform the clinical analysis in an efficient way. MEG data import, spike detection, dipole analysis and clustering are included in the protocol and all results are presented in a Word report document.
While performing the review and analysis of the data the user can switch between different pre-defined displays, suchs as EEG+MEG, MEG only, MEG+MRI etc. etc. All views are synchronized and for example, clicking on a dipole in the dipole clusters shows immediately the respective page of MEG/EEG data and corresponding 3D mapping.

These are just a few highlight of the capibilities of MaxInsight. Please contact Elekta Neuromag in case you wish to receive additional information.